Decheng Capital Global Life Sciences Fund IV, L.P., 10% Owner at Aardvark Therapeutics, Inc. (AARD), bought 2,958,887 shares at $16.00 ($10.0M) on 2025-02-14, disclosed to the SEC on 2025-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,333,887 | $0 | 0.0% |
| 2 | $16.00 | 625,000 | $10.0M | 100.0% |
| Total | $3.38 avg | 2,958,887 | $10.0M | 100% |